Hiroshima

Running trials

• Recruiting

  Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  NCT06855277· Phase 3· Source

• Active, not recruiting

  A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

  NCT06744920· Phase 3· Source

• Active, not recruiting

  A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

  NCT06470048· Phase 2· Source

• Active, not recruiting

  A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.

  NCT06517758· Phase 3· Source

• Active, not recruiting

  Specified Drug-use Survey of Leqvio for s.c. Injection.

  NCT06275724· Source

• Recruiting

  Special Drug Use-results Surveillance of Tafinlar/Mekinist

  NCT06262919· Source

• Recruiting

  Study of Out of Specification for Tisagenlecleucel

  NCT04094311· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Prostate cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy

  NCT06236061· Phase 3· Source

• Completed

  Special Drug Use Surveillance of Entresto Tablets (Hypertension)

  NCT05976230· Source

• Completed

  Special Drug Use-results Surveillance of Scemblix Tablets

  NCT05421091· Source

• Completed

  LUTATHERA Injection General Use Result Survey

  NCT05844332· Source

• Completed

  Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen

  NCT04940065· Source

• Completed

  Special Drug Use-results Surveillance of Tabrecta Tablets

  NCT04575025· Source